期刊文献+

绝经后骨质疏松患者骨组织中miR-124-3p、miR-328-3p、miR-338-3p的表达 被引量:1

Expression of miR-124-3p,miR-328-3p and miR-338-3p in bone tissue of postmenopausal osteoporosis patients
下载PDF
导出
摘要 目的:探讨绝经后骨质疏松患者骨组织中miR-124-3p、miR-328-3p、miR-338-3p表达。方法:选取30例绝经后骨质疏松妇女(PMOP组)和30例非骨质疏松的绝经后妇女(对照组),髂前上棘穿刺取骨组织300mg,研磨、匀浆,通过RT-qPCR方法分析检测两组miR-124-3p、miR-328-3p、miR-338-3p的表达水平。结果:miR-338-3p在PMOP组骨组织中的表达水平升高;miR-124-3p、miR-328-3p在PMOP组骨组织中的表达水平降低。结论:miR-124-3p、miR-328-3p、miR-338-3p可调节成骨、破骨引起PMOP,可通过调控其表达干预PMOP的发生和治疗。 Objective To investigate the expression of miR-124-3p,miR-328-3p and miR-338-3p in bone tissue of postmenopausal osteoporosis patients.Method A total of 30 postmenopausal osteoporosis women(PMOP group)and 30 non-osteoporosis postmenopausal women(control group)were selected.At the same time,300 mg of bone tissue was extracted from anterior superior iliac spine puncture.Grinded and homogenated.The expression levels ofmiR-124-3p,miR-328-3p and miR-338-3p were detected by RT-qPCR analysis in two groups.Results The expression level of miR-338-3p in bone tissue of PMOP group was increased,and the expression level of miR-124-3p and miR-328-3p in bone tissue of PMOP group was decreased.Conclusion MiR-124-3p,miR-328-3p and miR-338-3p can regulate osteogenesis and osteoclastogenesis to cause PMOP,and can intervene the occurrence and treatment of PMOP by regulating its expression.
作者 牟朋林 麦彩园 曹燕明 王斌 MOU Peng-lin;MAI Cai-yuan;CAO Yan-ming;无(Guangzhou Xinhai Hospital,Guangzhou 510080,China;Guangdong Women and Children's Hospital,Guangzhou 510010,China;The Second Affiliated Hospital of Guangzhou Medical University,Guangzhou 510260,China;The People's Hospital of Sanshui,Foshan,Foshan528100,China)
出处 《吉林医学》 CAS 2022年第7期1771-1774,共4页 Jilin Medical Journal
基金 国家自然科学基金[项目编号:81574002] 广东省医学科学技术研究基金[项目编号:A2020377] 佛山市科技局科研立项[项目编号:2018AB000595]。
关键词 绝经后骨质疏松 miR-124-3p miR-328-3p miR-338-3p Postmenopausal osteoporosis MiR-124-3p MiR-328-3p MiR-338-3p
  • 相关文献

参考文献6

二级参考文献39

  • 1Vel6zquez-Cruz R, Garcia-Ortiz I-I, Castillejos-L6pez M, et al. WNT3A gene polymorphisms are associated with bone min- eral density variation in postmenopausal mestizo women of an urban Mexican population: findings of a pathway-based high- density single nucleotide screening[J]. Age (Dord), 2014, 36 (3): 9635.
  • 2Kurt-Sirin 0, Yilmaz-Aydogan I-I, Uyar M, et al. Combined effects of collagen type I alphal ( COL1A1 ) Spl polymorphism and osteoporosis risk factors on bone mineral density in Turkishpostmenopausal women [J].Gene,2014,540 ( 2 ) : 226-231.
  • 3Mohiti-Ardekani J, Soleymani-Salehabadi H, Owlia MB, et al. Relationships between serum adipocyte hormones (adipone- ctin, leptin, resistin), bone mineral density and bone metabol- ic markers in osteoporosis patients [J]. J Bone Miner Metab, 2014, 32 (4): 400-404.
  • 4Kurtoglu-Aksoy N, Akhan SE, Bastu E, et al. Implications of premature ovarian failure on bone turnover markers and bone mineral density [J].Clin Exp Obstet Gynecol, 2014, 41 (2) : 149-153.
  • 5Mucowski SJ, Mack WJ, Shoupe D, et al. Effect of prior o- ophorectomy on changes in bone mineral density and carotid artery intima- media thickness in postmenopausaI women[J]. Fertil Steril, 2014, 101 (4): 1117-1122.
  • 6李联祥,王黎光,申育华,高金生.正常及异常组织中雌激素α及β受体的表达[J].中国组织工程研究与临床康复,2010,14(50):9442-9446. 被引量:3
  • 7原发性骨质疏松症诊治指南(2011年)[J].中华骨质疏松和骨矿盐疾病杂志,2011,4(1):2-17. 被引量:1830
  • 8郭华平,郁嫣嫣,陈文华,余波,祁奇.绝经后骨质疏松症发病相关危险因素分析及预防措施探讨[J].中国康复医学杂志,2011,26(5):424-428. 被引量:62
  • 9黄立莉,洪文,王立源,何涓,吕小华,王碧云.绝经后骨质疏松症的临床治疗进展[J].中国医药导报,2011,8(18):7-10. 被引量:46
  • 10夏维波.骨质疏松症的联合治疗与序贯治疗[J].中华骨质疏松和骨矿盐疾病杂志,2011,4(2):73-81. 被引量:19

共引文献1439

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部